Annual report pursuant to Section 13 and 15(d)

Earnings (Loss) Per Common Share (Details)

v3.10.0.1
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Basic and diluted numerator:    
Net loss attributable to iBio, Inc. stockholders $ (16,105) $ (14,532)
Preferred stock dividends (260) (90)
Net loss available to iBio, Inc. stockholders $ (16,365) $ (14,622)
Basic and diluted denominator:    
Weighted-average common shares outstanding 10,631 8,911
Per share amount $ (1.54) $ (1.64)